MikeMareen/iStock via Getty Images
I last wrote on Palantir Technologies Inc. (NASDAQ:PLTR) in early May, and I’m updating my thoughts on the stock in light of the latest news and the stock movement since then. But before I get
Don't Like The Price? Don't Exit: Palantir Remains A Buy In My Books
Summary
- I maintain my long-term buy on Palantir Technologies Inc., but I advise investors to be cautious at current levels due to potential near-term volatility.
- Palantir’s fundamentals remain solid, driven by expanding government contracts, defense deals, and new partnerships in healthcare and finance.
- Valuation is stretched, leaving little room for execution errors.
- Despite ethical controversies and market noise, I recommend adding on pullbacks, focusing on Palantir’s business momentum rather than just its premium valuation.
- I hereon share my sentiment on PLTR stock and why I see more upside over the medium term.
I’m a retired Wall Street PM specializing in TMT; since kickstarting my career, I’ve spent over two decades in the market navigating the technology landscape, focusing on risk mitigation through the dot com bubble, credit default of ‘08, and, more recently, with the AI boom. In one word, what I’d like my service to revolve around is momentum.
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.